Genocea Biosciences - Articles and news items

Genocea announces positive top-line data from Phase 2 GEN-003 optimisation trial

Industry news / 20 May 2015 / Victoria White

Genocea Biosciences has announced positive top-line data from a Phase 2 dose optimisation trial evaluating GEN-003 for the treatment of genital herpes…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+